Kala制药 KALA 深 沪
等待开盘 04-01 09:30:00 美东时间
0.1731
+0.002
+1.23%
华盛通- 最 高0.1799
- 今 开0.1699
- 成交量 203.82万股
- 最 低 0.1658
- 昨 收 0.171
- 总市值 1.58亿
- 52周最高 20.60
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 0.1607
- 委 比 66.67%
- 总股本 9.11亿
- 历史最高 1337.50
- 量 比 0.60
- 振 幅 8.25%
- 历史最低 0.1607
- 每 手 1
- 风险率 4.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kala Bio Highlights Launch Of Agentic AI Platform
The Bionic Intelligence Research Agent is a fully autonomous AI research specialist built for the biotechnology and pharmaceutical sectors
03-30 20:32
EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch
Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a potential recurring revenue model.
03-30 20:31
美股牛股 | OCUGEN飙升近30%，机构首次覆盖该公司并给予高额目标价；纳微半导体大涨近25%
OCUGEN飙升近30%，机构首次覆盖该公司并给予高额目标价；纳微半导体大涨近25%，推出适用于人工智能数据中心的两款新产品>>
03-12 16:40
Kala Bio Chases 'Palantir For Biotech' Dream With New AI Platform
Is KALA the Palantir of biotech? Kala Bio Inc. pivots to agentic AI with a new platform shipping in 2 weeks. Read the full update.
03-11 20:08
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05
KALA BIO Announces Strategic Initiative To Build On-Premises AI Infrastructure Platform To Be Deployed Directly Within Biotech And Pharmaceutical Client Environments
Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry — to deploy secure, on-premises AI systems directly within client environments where proprietary data never
03-04 19:33
Kala Bio shares are trading higher after the company settled approximately $10.6 million of debt.
Kala Bio shares are trading higher after the company settled approximately $10....
01-06 05:13
KALA BIO Completes Oxford Finance Loan Settlement With $2M Payment, Resolving ~$10.6M Debt
KALA BIO, Inc. (NASDAQ:KALA), ("KALA" or the "Company") today announced the successful completion of its loan settlement with Oxford Finance, LLC ("Oxford"), marking a transformational milestone for the Company. The
01-06 05:11
KALA BIO Settles Approximately $10.6 million of Debt
KALA BIO, Inc. announced the successful completion of itsloan settlement with Oxford Finance, resolving a debt obligation of approximately $10.6 million. The company paid a final $2 million, settling all obligations under the Loan Agreement and Settlement Agreement. CEO David Lazar highlighted this as a transformative step, enhancing strategic flexibility and stockholders' equity. Additionally, KALA granted 400,000 shares of common stock to four ...
01-05 21:10
KALA BIO to raise $10 mln in registered direct offering
KALA BIO (NASDAQ:KALA) on Thursday said that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 shares of its common stock, at $1.00 per share in a registered di...
2025-12-04 23:55
